Viewing Study NCT01053806


Ignite Creation Date: 2025-12-26 @ 1:17 PM
Ignite Modification Date: 2026-01-14 @ 2:05 AM
Study NCT ID: NCT01053806
Status: UNKNOWN
Last Update Posted: 2012-09-25
First Post: 2010-01-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDS View
None Lenalidomide View
None 5-Azacytidine. View
None ORR View
None PFS View
None myelodysplastic syndrome.High risk. View